Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Biallelic Human Sharpin Loss of Function Induces Autoinflammation and Immunodeficiency Publisher Pubmed



Oda H1, 2, 3 ; Manthiram K1, 4 ; Chavan PP1 ; Rieser E2, 5 ; Veli O2 ; Kaya O2 ; Rauch C2, 5 ; Nakabo S6 ; Kuehn HS7 ; Swart M2 ; Wang Y2 ; Celik NI2 ; Molitor A8, 9 ; Ziaee V10, 11, 12, 13 Show All Authors
Authors
  1. Oda H1, 2, 3
  2. Manthiram K1, 4
  3. Chavan PP1
  4. Rieser E2, 5
  5. Veli O2
  6. Kaya O2
  7. Rauch C2, 5
  8. Nakabo S6
  9. Kuehn HS7
  10. Swart M2
  11. Wang Y2
  12. Celik NI2
  13. Molitor A8, 9
  14. Ziaee V10, 11, 12, 13
  15. Movahedi N11, 12, 14
  16. Shahrooei M15, 16
  17. Parvaneh N11, 17
  18. Alipourolyei N8, 9
  19. Carapito R8, 9, 18
  20. Xu Q4
  21. Preite S4
  22. Beck DB1, 19, 20
  23. Chae JJ1
  24. Nehrebecky M1
  25. Ombrello AK1
  26. Hoffmann P1
  27. Romeo T1
  28. Deuitch NT1
  29. Matthiasardottir B1
  30. Mullikin J1
  31. Komarow H4
  32. Stoddard J7
  33. Niemela J7
  34. Dobbs K4
  35. Sweeney CL4
  36. Anderton H21, 22
  37. Lawlor KE21, 22, 23, 24
  38. Yoshitomi H25, 26, 27
  39. Yang D28
  40. Boehm M28
  41. Davis J29
  42. Mudd P30
  43. Randazzo D6
  44. Tsai WL6
  45. Gadina M6
  46. Kaplan MJ6
  47. Toguchida J25, 26
  48. Mayer CT29
  49. Rosenzweig SD7
  50. Notarangelo LD4
  51. Iwai K27
  52. Silke J21, 22
  53. Schwartzberg PL4
  54. Boisson B31, 32, 33
  55. Casanova JL31, 32, 33, 34, 35
  56. Bahram S8, 9, 18
  57. Rao AP36
  58. Peltzer N2, 37, 38
  59. Walczak H2, 5, 39
  60. Lalaoui N21, 40, 41
  61. Aksentijevich I1
  62. Kastner DL1
Show Affiliations
Authors Affiliations
  1. 1. National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, United States
  2. 2. Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany
  3. 3. Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
  4. 4. National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States
  5. 5. Institute of Biochemistry I, Medical Faculty, University of Cologne, Cologne, Germany
  6. 6. National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, United States
  7. 7. Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD, United States
  8. 8. Laboratoire d’ImmunoRhumatologie Moleculaire, INSERM UMR_S1109, Plateforme GENOMAX, Faculte de Medecine, Federation Hospitalo-Universitaire OMICARE, Centre de Recherche d’Immunologie et d’Hematologie, CRBS, Federation de Medecine Translationnelle de Strasbourg, Universite de Strasbourg, Strasbourg, France
  9. 9. Institut Thematique Interdisciplinaire (ITI) de Medecine de Precision de Strasbourg, Strasbourg, France
  10. 10. Division of Rheumatology, Department of Pediatrics, Tehran University of Medical Sciences, Tehran, Iran
  11. 11. Children’s Medical Center, Pediatrics Center of Excellence, Tehran, Iran
  12. 12. Pediatric Rheumatology Society of Iran, Tehran, Iran
  13. 13. Pediatric Rheumatology Research Group, Rheumatology Research Center, Tehran, Iran
  14. 14. School of Medicine, Golestan University of Medical Sciences, Gorgan, Iran
  15. 15. Clinical and Diagnostic Immunology, Department of Microbiology, Immunology, and Transplantation, KU Leuven, Leuven, Belgium
  16. 16. Dr. Shahrooei Lab, 22 Bahman St., Ashrafi Esfahani Blvd, Tehran, Iran
  17. 17. Division of Allergy and Clinical Immunology, Department of Pediatrics, Tehran University of Medical Sciences, Tehran, Iran
  18. 18. Laboratoire d’Immunologie, Plateau Technique de Biologie, Pole de Biologie, Nouvel Hopital Civil, Strasbourg, France
  19. 19. Center for Human Genetics and Genomics, New York University Grossman School of Medicine, New York, NY, United States
  20. 20. Division of Rheumatology, Department of Medicine, New York University Grossman School of Medicine, New York, NY, United States
  21. 21. The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia
  22. 22. Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia
  23. 23. Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, VIC, Australia
  24. 24. Department of Molecular and Translational Science, Monash University, Clayton, VIC, Australia
  25. 25. Institute for Life and Medical Sciences, Kyoto University, Kyoto, Japan
  26. 26. Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan
  27. 27. Graduate School of Medicine, Kyoto University, Kyoto, Japan
  28. 28. National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, United States
  29. 29. National Cancer Institute, National Institutes of Health, Bethesda, MD, United States
  30. 30. Division of Pediatric Otolaryngology, Children’s National Hospital, Washington, DC, United States
  31. 31. St. Giles Laboratory of Human Genetics of Infectious Diseases, The Rockefeller University, New York, NY, United States
  32. 32. Laboratory of Human Genetics of Infectious Diseases, INSERM, Necker Hospital for Sick Children, Paris, France
  33. 33. Imagine Institute, Paris Cite University, Paris, France
  34. 34. Department of Pediatrics, Necker Hospital for Sick Children, Paris, France
  35. 35. Howard Hughes Medical Institute, The Rockefeller University, New York, NY, United States
  36. 36. Manipal Hospital, Bengaluru, India
  37. 37. Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany
  38. 38. Department of Translational Genomics, University of Cologne, Cologne, Germany
  39. 39. Centre for Cell Death, Cancer, and Inflammation, UCL Cancer Institute, University College, London, United Kingdom
  40. 40. Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
  41. 41. Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia

Source: Nature Immunology Published:2024


Abstract

The linear ubiquitin assembly complex (LUBAC) consists of HOIP, HOIL-1 and SHARPIN and is essential for proper immune responses. Individuals with HOIP and HOIL-1 deficiencies present with severe immunodeficiency, autoinflammation and glycogen storage disease. In mice, the loss of Sharpin leads to severe dermatitis due to excessive keratinocyte cell death. Here, we report two individuals with SHARPIN deficiency who manifest autoinflammatory symptoms but unexpectedly no dermatological problems. Fibroblasts and B cells from these individuals showed attenuated canonical NF-κB responses and a propensity for cell death mediated by TNF superfamily members. Both SHARPIN-deficient and HOIP-deficient individuals showed a substantial reduction of secondary lymphoid germinal center B cell development. Treatment of one SHARPIN-deficient individual with anti-TNF therapies led to complete clinical and transcriptomic resolution of autoinflammation. These findings underscore the critical function of the LUBAC as a gatekeeper for cell death-mediated immune dysregulation in humans. © This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2024.